Bristol-Myers surprise: Threatened I-O drug Opdivo stands its ground in lung cancer
admin 26th July 2018 Uncategorised 0Investors may be worried about Bristol-Myers Squibb’s future in lung cancer, but in the meantime, the company’s portfolio is firing on all cylinders. Nearly all of the company’s key products surpassed sales expectations for the second quarter.
More: Bristol-Myers surprise: Threatened I-O drug Opdivo stands its ground in lung cancer
Source: fierce